Shenzhen Chipscreen Biosciences Co (688321) — Cash Flow Reinvestment Rate

Latest as of September 2025: 27.48x

Shenzhen Chipscreen Biosciences Co (688321) has a Cash Flow Reinvestment Rate of 27.48x as of September 2025, reinvesting CN¥61.73 Million (capex CN¥61.73 Million ) from operating cash flow of CN¥2.25 Million. See 688321 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

27.48x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥61.73 Million
Capex + Investments

Operating Cash Flow

CN¥2.25 Million
CNY

Capital Expenditures

CN¥61.73 Million
CNY

Shenzhen Chipscreen Biosciences Co Cash Flow Reinvestment Rate (2016–2024)

Historical reinvestment intensity for Shenzhen Chipscreen Biosciences Co across 7 annual periods. For the full cash flow conversion analysis, see Shenzhen Chipscreen Biosciences Co cash flow conversion.

Annual Cash Flow Reinvestment Rate for Shenzhen Chipscreen Biosciences Co (2016–2024)

Year-by-year capital reinvestment analysis for Shenzhen Chipscreen Biosciences Co. See Shenzhen Chipscreen Biosciences Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 3.89x CN¥296.04 Million CN¥76.13 Million CN¥268.49 Million ▼ -86.0%
2022 27.76x CN¥1.20 Billion CN¥43.30 Million CN¥400.17 Million ▲ +548.7%
2021 4.28x CN¥534.01 Million CN¥124.78 Million CN¥288.46 Million ▼ -26.2%
2020 5.80x CN¥542.98 Million CN¥93.62 Million CN¥336.27 Million ▼ -50.5%
2018 11.71x CN¥266.74 Million CN¥22.78 Million CN¥140.74 Million ▼ -83.9%
2017 72.82x CN¥198.82 Million CN¥2.73 Million CN¥132.82 Million ▲ +2060.9%
2016 3.37x CN¥201.41 Million CN¥59.77 Million CN¥65.81 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow